Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Growth 2025-2031
The global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is a term that describes the systemic disorder that affects the bones, heart, and blood vessels of people with chronic kidney disease (CKD). CKD-MBD is caused by the abnormal function of the kidneys, which cannot filter blood and regulate hormones properly. This leads to imbalances in calcium, phosphorus, parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), and vitamin D metabolism. These imbalances can result in bone abnormalities, such as low or high bone turnover, mineralization defects, fractures, and growth impairment. They can also cause extraskeletal calcification, which is the deposition of calcium and phosphorus in the blood vessels and other tissues, increasing the risk of cardiovascular complications and mortality.
The future market trends of CKD-MBD treatment are influenced by several factors, such as the increasing prevalence of CKD, the aging population, the rising awareness and diagnosis of CKD-MBD, the development of novel and effective therapies, and the unmet medical needs of patients with CKD-MBD. Some of the current and emerging therapies for CKD-MBD include medications and supplements, such as phosphate binders, vitamin D analogs, calcimimetics, iron, and erythropoiesis-stimulating agents (ESAs); dialysis, which removes excess fluid and waste products from the blood; surgery, such as parathyroidectomy, which removes the overactive parathyroid glands; diet, which restricts the intake of phosphorus, calcium, and protein; and others, such as bone-modifying agents, calcification inhibitors, and FGF23 inhibitors. The market for CKD-MBD treatment is expected to grow due to the high demand for these therapies, the innovation and advancement in technology, the increasing investment and research in this field, and the expansion of the target population.
LP Information, Inc. (LPI) ' newest research report, the “Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Forecast” looks at past sales and reviews total world Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales in 2024, providing a comprehensive analysis by region and market sector of projected Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales for 2025 through 2031. With Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) industry.
This Insight Report provides a comprehensive analysis of the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD).
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market?
What factors are driving Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market opportunities vary by end market size?
How does Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is a term that describes the systemic disorder that affects the bones, heart, and blood vessels of people with chronic kidney disease (CKD). CKD-MBD is caused by the abnormal function of the kidneys, which cannot filter blood and regulate hormones properly. This leads to imbalances in calcium, phosphorus, parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), and vitamin D metabolism. These imbalances can result in bone abnormalities, such as low or high bone turnover, mineralization defects, fractures, and growth impairment. They can also cause extraskeletal calcification, which is the deposition of calcium and phosphorus in the blood vessels and other tissues, increasing the risk of cardiovascular complications and mortality.
The future market trends of CKD-MBD treatment are influenced by several factors, such as the increasing prevalence of CKD, the aging population, the rising awareness and diagnosis of CKD-MBD, the development of novel and effective therapies, and the unmet medical needs of patients with CKD-MBD. Some of the current and emerging therapies for CKD-MBD include medications and supplements, such as phosphate binders, vitamin D analogs, calcimimetics, iron, and erythropoiesis-stimulating agents (ESAs); dialysis, which removes excess fluid and waste products from the blood; surgery, such as parathyroidectomy, which removes the overactive parathyroid glands; diet, which restricts the intake of phosphorus, calcium, and protein; and others, such as bone-modifying agents, calcification inhibitors, and FGF23 inhibitors. The market for CKD-MBD treatment is expected to grow due to the high demand for these therapies, the innovation and advancement in technology, the increasing investment and research in this field, and the expansion of the target population.
LP Information, Inc. (LPI) ' newest research report, the “Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Forecast” looks at past sales and reviews total world Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales in 2024, providing a comprehensive analysis by region and market sector of projected Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales for 2025 through 2031. With Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) industry.
This Insight Report provides a comprehensive analysis of the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD).
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Control Hyperphosphatemia
- Maintain Blood Calcium Levels
- Control PTH Level
- Correct Acidosis
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Akebia
- Astellas
- Takeda
- Vifor
- Abbvie
- Fresenius
- Abbott
- Novadiol
- Japan Tobacco Company
- Daiichi-Sankyo
- Shield
- Spectrum
- OPKO
- Ardelyx
- Sanofi Genzyme
- Amgen
What is the 10-year outlook for the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market?
What factors are driving Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market opportunities vary by end market size?
How does Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country/Region, 2020, 2024 & 2031
2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Type
2.2.1 Control Hyperphosphatemia
2.2.2 Maintain Blood Calcium Levels
2.2.3 Control PTH Level
2.2.4 Correct Acidosis
2.2.5 Others
2.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type
2.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2020-2025)
2.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Type (2020-2025)
2.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.4.4 Drug Stores
2.4.5 Others
2.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application
2.5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Market Share by Application (2020-2025)
2.5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Breakdown Data by Company
3.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Company (2020-2025)
3.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Company (2020-2025)
3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Company (2020-2025)
3.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2020-2025)
3.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company (2020-2025)
3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Company
3.4 Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Location Distribution
3.4.2 Players Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CHRONIC KIDNEY DISEASE–MINERAL AND BONE DISORDERS (CKD-MBD) BY GEOGRAPHIC REGION
4.1 World Historic Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Geographic Region (2020-2025)
4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country/Region (2020-2025)
4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
4.4 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
4.5 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
4.6 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
5 AMERICAS
5.1 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
5.1.1 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025)
5.1.2 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2025)
5.2 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025)
5.3 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region
6.1.1 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2020-2025)
6.1.2 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2020-2025)
6.2 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025)
6.3 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
7.1.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025)
7.1.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2025)
7.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025)
7.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
8.1.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2025)
8.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025)
8.3 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
10.3 Manufacturing Process Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
10.4 Industry Chain Structure of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors
11.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customer
12 WORLD FORECAST REVIEW FOR CHRONIC KIDNEY DISEASE–MINERAL AND BONE DISORDERS (CKD-MBD) BY GEOGRAPHIC REGION
12.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Region
12.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Region (2026-2031)
12.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Type (2026-2031)
12.7 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Akebia
13.1.1 Akebia Company Information
13.1.2 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.1.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Akebia Main Business Overview
13.1.5 Akebia Latest Developments
13.2 Astellas
13.2.1 Astellas Company Information
13.2.2 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.2.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Astellas Main Business Overview
13.2.5 Astellas Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.3.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Vifor
13.4.1 Vifor Company Information
13.4.2 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.4.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Vifor Main Business Overview
13.4.5 Vifor Latest Developments
13.5 Abbvie
13.5.1 Abbvie Company Information
13.5.2 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Abbvie Main Business Overview
13.5.5 Abbvie Latest Developments
13.6 Fresenius
13.6.1 Fresenius Company Information
13.6.2 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.6.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Fresenius Main Business Overview
13.6.5 Fresenius Latest Developments
13.7 Abbott
13.7.1 Abbott Company Information
13.7.2 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.7.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Abbott Main Business Overview
13.7.5 Abbott Latest Developments
13.8 Novadiol
13.8.1 Novadiol Company Information
13.8.2 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.8.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Novadiol Main Business Overview
13.8.5 Novadiol Latest Developments
13.9 Japan Tobacco Company
13.9.1 Japan Tobacco Company Company Information
13.9.2 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.9.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Japan Tobacco Company Main Business Overview
13.9.5 Japan Tobacco Company Latest Developments
13.10 Daiichi-Sankyo
13.10.1 Daiichi-Sankyo Company Information
13.10.2 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Daiichi-Sankyo Main Business Overview
13.10.5 Daiichi-Sankyo Latest Developments
13.11 Shield
13.11.1 Shield Company Information
13.11.2 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.11.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Shield Main Business Overview
13.11.5 Shield Latest Developments
13.12 Spectrum
13.12.1 Spectrum Company Information
13.12.2 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.12.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Spectrum Main Business Overview
13.12.5 Spectrum Latest Developments
13.13 OPKO
13.13.1 OPKO Company Information
13.13.2 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.13.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 OPKO Main Business Overview
13.13.5 OPKO Latest Developments
13.14 Ardelyx
13.14.1 Ardelyx Company Information
13.14.2 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.14.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Ardelyx Main Business Overview
13.14.5 Ardelyx Latest Developments
13.15 Sanofi Genzyme
13.15.1 Sanofi Genzyme Company Information
13.15.2 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.15.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Sanofi Genzyme Main Business Overview
13.15.5 Sanofi Genzyme Latest Developments
13.16 Amgen
13.16.1 Amgen Company Information
13.16.2 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.16.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Amgen Main Business Overview
13.16.5 Amgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country/Region, 2020, 2024 & 2031
2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Type
2.2.1 Control Hyperphosphatemia
2.2.2 Maintain Blood Calcium Levels
2.2.3 Control PTH Level
2.2.4 Correct Acidosis
2.2.5 Others
2.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type
2.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2020-2025)
2.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Type (2020-2025)
2.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.4.4 Drug Stores
2.4.5 Others
2.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application
2.5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Market Share by Application (2020-2025)
2.5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Breakdown Data by Company
3.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Company (2020-2025)
3.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Company (2020-2025)
3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Company (2020-2025)
3.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2020-2025)
3.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company (2020-2025)
3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Company
3.4 Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Location Distribution
3.4.2 Players Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CHRONIC KIDNEY DISEASE–MINERAL AND BONE DISORDERS (CKD-MBD) BY GEOGRAPHIC REGION
4.1 World Historic Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Geographic Region (2020-2025)
4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country/Region (2020-2025)
4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
4.4 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
4.5 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
4.6 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
5 AMERICAS
5.1 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
5.1.1 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025)
5.1.2 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2025)
5.2 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025)
5.3 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region
6.1.1 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2020-2025)
6.1.2 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2020-2025)
6.2 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025)
6.3 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
7.1.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025)
7.1.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2025)
7.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025)
7.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
8.1.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2025)
8.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025)
8.3 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
10.3 Manufacturing Process Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
10.4 Industry Chain Structure of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors
11.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customer
12 WORLD FORECAST REVIEW FOR CHRONIC KIDNEY DISEASE–MINERAL AND BONE DISORDERS (CKD-MBD) BY GEOGRAPHIC REGION
12.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Region
12.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Region (2026-2031)
12.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Type (2026-2031)
12.7 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Akebia
13.1.1 Akebia Company Information
13.1.2 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.1.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Akebia Main Business Overview
13.1.5 Akebia Latest Developments
13.2 Astellas
13.2.1 Astellas Company Information
13.2.2 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.2.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Astellas Main Business Overview
13.2.5 Astellas Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.3.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Vifor
13.4.1 Vifor Company Information
13.4.2 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.4.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Vifor Main Business Overview
13.4.5 Vifor Latest Developments
13.5 Abbvie
13.5.1 Abbvie Company Information
13.5.2 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Abbvie Main Business Overview
13.5.5 Abbvie Latest Developments
13.6 Fresenius
13.6.1 Fresenius Company Information
13.6.2 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.6.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Fresenius Main Business Overview
13.6.5 Fresenius Latest Developments
13.7 Abbott
13.7.1 Abbott Company Information
13.7.2 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.7.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Abbott Main Business Overview
13.7.5 Abbott Latest Developments
13.8 Novadiol
13.8.1 Novadiol Company Information
13.8.2 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.8.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Novadiol Main Business Overview
13.8.5 Novadiol Latest Developments
13.9 Japan Tobacco Company
13.9.1 Japan Tobacco Company Company Information
13.9.2 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.9.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Japan Tobacco Company Main Business Overview
13.9.5 Japan Tobacco Company Latest Developments
13.10 Daiichi-Sankyo
13.10.1 Daiichi-Sankyo Company Information
13.10.2 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Daiichi-Sankyo Main Business Overview
13.10.5 Daiichi-Sankyo Latest Developments
13.11 Shield
13.11.1 Shield Company Information
13.11.2 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.11.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Shield Main Business Overview
13.11.5 Shield Latest Developments
13.12 Spectrum
13.12.1 Spectrum Company Information
13.12.2 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.12.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Spectrum Main Business Overview
13.12.5 Spectrum Latest Developments
13.13 OPKO
13.13.1 OPKO Company Information
13.13.2 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.13.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 OPKO Main Business Overview
13.13.5 OPKO Latest Developments
13.14 Ardelyx
13.14.1 Ardelyx Company Information
13.14.2 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.14.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Ardelyx Main Business Overview
13.14.5 Ardelyx Latest Developments
13.15 Sanofi Genzyme
13.15.1 Sanofi Genzyme Company Information
13.15.2 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.15.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Sanofi Genzyme Main Business Overview
13.15.5 Sanofi Genzyme Latest Developments
13.16 Amgen
13.16.1 Amgen Company Information
13.16.2 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.16.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Amgen Main Business Overview
13.16.5 Amgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Control Hyperphosphatemia
Table 4. Major Players of Maintain Blood Calcium Levels
Table 5. Major Players of Control PTH Level
Table 6. Major Players of Correct Acidosis
Table 7. Major Players of Others
Table 8. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025) & (MT)
Table 9. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2020-2025)
Table 10. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2020-2025) & ($ million)
Table 11. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2020-2025)
Table 12. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Type (2020-2025) & (USD/Kg)
Table 13. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale by Application (2020-2025) & (MT)
Table 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Market Share by Application (2020-2025)
Table 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2020-2025) & ($ million)
Table 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2020-2025)
Table 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Application (2020-2025) & (USD/Kg)
Table 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company (2020-2025) & (MT)
Table 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Company (2020-2025)
Table 20. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company (2020-2025)
Table 22. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Company (2020-2025) & (USD/Kg)
Table 23. Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Producing Area Distribution and Sales Area
Table 24. Players Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
Table 25. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Geographic Region (2020-2025) & (MT)
Table 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Geographic Region (2020-2025)
Table 30. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country/Region (2020-2025) & (MT)
Table 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country/Region (2020-2025)
Table 34. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025) & (MT)
Table 37. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2020-2025)
Table 38. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025) & (MT)
Table 40. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025) & (MT)
Table 41. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2020-2025) & (MT)
Table 42. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2020-2025)
Table 43. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025) & (MT)
Table 45. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025) & (MT)
Table 46. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025) & (MT)
Table 47. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025) & (MT)
Table 49. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025) & (MT)
Table 50. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025) & (MT)
Table 51. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025) & (MT)
Table 53. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025) & (MT)
Table 54. Key Market Drivers & Growth Opportunities of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Table 55. Key Market Challenges & Risks of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Table 56. Key Industry Trends of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Table 57. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors List
Table 60. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customer List
Table 61. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Region (2026-2031) & (MT)
Table 62. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2026-2031) & (MT)
Table 64. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Region (2026-2031) & (MT)
Table 66. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2026-2031) & (MT)
Table 68. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2026-2031) & (MT)
Table 70. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Type (2026-2031) & (MT)
Table 72. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Application (2026-2031) & (MT)
Table 74. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Akebia Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 76. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 77. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 78. Akebia Main Business
Table 79. Akebia Latest Developments
Table 80. Astellas Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 81. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 82. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 83. Astellas Main Business
Table 84. Astellas Latest Developments
Table 85. Takeda Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 86. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 87. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 88. Takeda Main Business
Table 89. Takeda Latest Developments
Table 90. Vifor Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 91. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 92. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 93. Vifor Main Business
Table 94. Vifor Latest Developments
Table 95. Abbvie Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 96. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 97. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 98. Abbvie Main Business
Table 99. Abbvie Latest Developments
Table 100. Fresenius Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 101. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 102. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 103. Fresenius Main Business
Table 104. Fresenius Latest Developments
Table 105. Abbott Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 106. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 107. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 108. Abbott Main Business
Table 109. Abbott Latest Developments
Table 110. Novadiol Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 111. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 112. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 113. Novadiol Main Business
Table 114. Novadiol Latest Developments
Table 115. Japan Tobacco Company Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 116. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 117. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 118. Japan Tobacco Company Main Business
Table 119. Japan Tobacco Company Latest Developments
Table 120. Daiichi-Sankyo Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 121. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 122. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 123. Daiichi-Sankyo Main Business
Table 124. Daiichi-Sankyo Latest Developments
Table 125. Shield Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 126. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 127. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 128. Shield Main Business
Table 129. Shield Latest Developments
Table 130. Spectrum Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 131. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 132. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 133. Spectrum Main Business
Table 134. Spectrum Latest Developments
Table 135. OPKO Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 136. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 137. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 138. OPKO Main Business
Table 139. OPKO Latest Developments
Table 140. Ardelyx Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 141. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 142. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 143. Ardelyx Main Business
Table 144. Ardelyx Latest Developments
Table 145. Sanofi Genzyme Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 146. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 147. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 148. Sanofi Genzyme Main Business
Table 149. Sanofi Genzyme Latest Developments
Table 150. Amgen Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 151. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 152. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 153. Amgen Main Business
Table 154. Amgen Latest Developments
Table 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Control Hyperphosphatemia
Table 4. Major Players of Maintain Blood Calcium Levels
Table 5. Major Players of Control PTH Level
Table 6. Major Players of Correct Acidosis
Table 7. Major Players of Others
Table 8. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025) & (MT)
Table 9. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2020-2025)
Table 10. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2020-2025) & ($ million)
Table 11. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2020-2025)
Table 12. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Type (2020-2025) & (USD/Kg)
Table 13. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale by Application (2020-2025) & (MT)
Table 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Market Share by Application (2020-2025)
Table 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2020-2025) & ($ million)
Table 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2020-2025)
Table 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Application (2020-2025) & (USD/Kg)
Table 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company (2020-2025) & (MT)
Table 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Company (2020-2025)
Table 20. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company (2020-2025)
Table 22. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Company (2020-2025) & (USD/Kg)
Table 23. Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Producing Area Distribution and Sales Area
Table 24. Players Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
Table 25. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Geographic Region (2020-2025) & (MT)
Table 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Geographic Region (2020-2025)
Table 30. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country/Region (2020-2025) & (MT)
Table 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country/Region (2020-2025)
Table 34. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025) & (MT)
Table 37. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2020-2025)
Table 38. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025) & (MT)
Table 40. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025) & (MT)
Table 41. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2020-2025) & (MT)
Table 42. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2020-2025)
Table 43. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025) & (MT)
Table 45. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025) & (MT)
Table 46. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025) & (MT)
Table 47. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025) & (MT)
Table 49. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025) & (MT)
Table 50. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2020-2025) & (MT)
Table 51. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2020-2025) & (MT)
Table 53. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2020-2025) & (MT)
Table 54. Key Market Drivers & Growth Opportunities of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Table 55. Key Market Challenges & Risks of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Table 56. Key Industry Trends of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Table 57. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors List
Table 60. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customer List
Table 61. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Region (2026-2031) & (MT)
Table 62. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2026-2031) & (MT)
Table 64. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Region (2026-2031) & (MT)
Table 66. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2026-2031) & (MT)
Table 68. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2026-2031) & (MT)
Table 70. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Type (2026-2031) & (MT)
Table 72. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Application (2026-2031) & (MT)
Table 74. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Akebia Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 76. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 77. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 78. Akebia Main Business
Table 79. Akebia Latest Developments
Table 80. Astellas Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 81. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 82. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 83. Astellas Main Business
Table 84. Astellas Latest Developments
Table 85. Takeda Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 86. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 87. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 88. Takeda Main Business
Table 89. Takeda Latest Developments
Table 90. Vifor Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 91. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 92. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 93. Vifor Main Business
Table 94. Vifor Latest Developments
Table 95. Abbvie Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 96. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 97. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 98. Abbvie Main Business
Table 99. Abbvie Latest Developments
Table 100. Fresenius Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 101. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 102. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 103. Fresenius Main Business
Table 104. Fresenius Latest Developments
Table 105. Abbott Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 106. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 107. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 108. Abbott Main Business
Table 109. Abbott Latest Developments
Table 110. Novadiol Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 111. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 112. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 113. Novadiol Main Business
Table 114. Novadiol Latest Developments
Table 115. Japan Tobacco Company Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 116. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 117. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 118. Japan Tobacco Company Main Business
Table 119. Japan Tobacco Company Latest Developments
Table 120. Daiichi-Sankyo Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 121. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 122. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 123. Daiichi-Sankyo Main Business
Table 124. Daiichi-Sankyo Latest Developments
Table 125. Shield Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 126. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 127. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 128. Shield Main Business
Table 129. Shield Latest Developments
Table 130. Spectrum Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 131. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 132. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 133. Spectrum Main Business
Table 134. Spectrum Latest Developments
Table 135. OPKO Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 136. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 137. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 138. OPKO Main Business
Table 139. OPKO Latest Developments
Table 140. Ardelyx Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 141. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 142. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 143. Ardelyx Main Business
Table 144. Ardelyx Latest Developments
Table 145. Sanofi Genzyme Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 146. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 147. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 148. Sanofi Genzyme Main Business
Table 149. Sanofi Genzyme Latest Developments
Table 150. Amgen Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 151. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 152. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 153. Amgen Main Business
Table 154. Amgen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure 2. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country/Region (2024)
Figure 10. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Control Hyperphosphatemia
Figure 12. Product Picture of Maintain Blood Calcium Levels
Figure 13. Product Picture of Control PTH Level
Figure 14. Product Picture of Correct Acidosis
Figure 15. Product Picture of Others
Figure 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type in 2025
Figure 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2020-2025)
Figure 18. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Hospital Pharmacies
Figure 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Hospital Pharmacies (2020-2025) & (MT)
Figure 20. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Retail Pharmacies
Figure 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Retail Pharmacies (2020-2025) & (MT)
Figure 22. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Online Pharmacies
Figure 23. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Online Pharmacies (2020-2025) & (MT)
Figure 24. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Drug Stores
Figure 25. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Drug Stores (2020-2025) & (MT)
Figure 26. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Others
Figure 27. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Others (2020-2025) & (MT)
Figure 28. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Market Share by Application (2024)
Figure 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application in 2025
Figure 30. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company in 2025 (MT)
Figure 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Company in 2025
Figure 32. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company in 2025 ($ millions)
Figure 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company in 2025
Figure 34. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2020-2025 (MT)
Figure 37. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2020-2025 ($ millions)
Figure 38. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2020-2025 (MT)
Figure 39. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2020-2025 ($ millions)
Figure 40. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2020-2025 (MT)
Figure 41. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2020-2025 (MT)
Figure 43. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2020-2025 ($ millions)
Figure 44. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2025
Figure 45. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2020-2025)
Figure 46. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2020-2025)
Figure 47. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2020-2025)
Figure 48. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region in 2025
Figure 53. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2020-2025)
Figure 54. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2020-2025)
Figure 55. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2020-2025)
Figure 56. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 60. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 62. China Taiwan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2025
Figure 64. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2020-2025)
Figure 65. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2020-2025)
Figure 66. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2020-2025)
Figure 67. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 68. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2020-2025)
Figure 74. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2020-2025)
Figure 75. Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 78. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in 2025
Figure 81. Manufacturing Process Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure 82. Industry Chain Structure of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure 83. Channels of Distribution
Figure 84. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Forecast by Region (2026-2031)
Figure 85. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Region (2026-2031)
Figure 86. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Type (2026-2031)
Figure 87. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Type (2026-2031)
Figure 88. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Application (2026-2031)
Figure 89. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure 2. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country/Region (2024)
Figure 10. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Control Hyperphosphatemia
Figure 12. Product Picture of Maintain Blood Calcium Levels
Figure 13. Product Picture of Control PTH Level
Figure 14. Product Picture of Correct Acidosis
Figure 15. Product Picture of Others
Figure 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type in 2025
Figure 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2020-2025)
Figure 18. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Hospital Pharmacies
Figure 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Hospital Pharmacies (2020-2025) & (MT)
Figure 20. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Retail Pharmacies
Figure 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Retail Pharmacies (2020-2025) & (MT)
Figure 22. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Online Pharmacies
Figure 23. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Online Pharmacies (2020-2025) & (MT)
Figure 24. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Drug Stores
Figure 25. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Drug Stores (2020-2025) & (MT)
Figure 26. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Others
Figure 27. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Others (2020-2025) & (MT)
Figure 28. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Market Share by Application (2024)
Figure 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application in 2025
Figure 30. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company in 2025 (MT)
Figure 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Company in 2025
Figure 32. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company in 2025 ($ millions)
Figure 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company in 2025
Figure 34. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2020-2025 (MT)
Figure 37. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2020-2025 ($ millions)
Figure 38. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2020-2025 (MT)
Figure 39. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2020-2025 ($ millions)
Figure 40. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2020-2025 (MT)
Figure 41. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2020-2025 (MT)
Figure 43. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2020-2025 ($ millions)
Figure 44. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2025
Figure 45. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2020-2025)
Figure 46. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2020-2025)
Figure 47. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2020-2025)
Figure 48. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region in 2025
Figure 53. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2020-2025)
Figure 54. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2020-2025)
Figure 55. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2020-2025)
Figure 56. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 60. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 62. China Taiwan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2025
Figure 64. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2020-2025)
Figure 65. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2020-2025)
Figure 66. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2020-2025)
Figure 67. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 68. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2020-2025)
Figure 74. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2020-2025)
Figure 75. Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 78. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in 2025
Figure 81. Manufacturing Process Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure 82. Industry Chain Structure of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure 83. Channels of Distribution
Figure 84. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Forecast by Region (2026-2031)
Figure 85. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Region (2026-2031)
Figure 86. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Type (2026-2031)
Figure 87. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Type (2026-2031)
Figure 88. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Application (2026-2031)
Figure 89. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global RNA Sequencing Technologies Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
100 pages
Global Adhesives and Sealants Market Growth 2025-2031
US$ 3,660.00
January 2025
124 pages
Global Axial Bone Densitometry Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
87 pages
